Concepedia

David H. Moore

DH

Statistics

Publications

59

Citations

5.7K

H-Index

36

Active since

1980

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Indiana University School of Medicine

Roswell Park Comprehensive Cancer Center

Gynecologic Oncology Group

The University of Texas MD Anderson Cancer Center

David H. Moore is an author at Indiana University – Purdue University Indianapolis specializing in medicine, oncology, and gynecologic oncology.

Publications per year

1980–2023

59

Publications

59

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

Krishnansu S. Tewari, Michael W. Sill, Richard T. Penson et al. · The Lancet · 2017 · 679 citations · Full text

Medicine, Gynecology, Oncology +6

Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

David H. Moore, John A. Blessing, Richard P. McQuellon et al. · Journal of Clinical Oncology · 2004 · 641 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma

Peter G. Rose, Stacy Nerenstone, Mark F. Brady et al. · New England Journal of Medicine · 2004 · 399 citations · Full text

Medicine, Oncology, Surgery +17

Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group

David H. Moore, Gillian Thomas, Gustavo S. Montana et al. · International Journal of Radiation Oncology*Biology*Physics · 1998 · 315 citations

Medicine, Oncology, Radiation Oncology +17

Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer.

Vincenzo Papa, Biancamaria Gliozzo, Clark Gm et al. · PubMed · 1993 · 252 citations

Medicine, Endocrinology, Oncology +13

1–5 of 59